mesalamine has been researched along with Duodenal Ulcer in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodríguez-Grau, Mdel C | 1 |
| Chaparro, M | 1 |
| Díaz, R | 1 |
| Gisbert, JP | 1 |
| van Iperen, CE | 1 |
| Visser, J | 1 |
| Otten, MH | 1 |
2 other studies available for mesalamine and Duodenal Ulcer
| Article | Year |
|---|---|
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Resistance; | 2014 |
[Does no Helicobacter pylori mean no duodenal ulcer?].
Topics: Adult; Aminosalicylic Acids; Crohn Disease; Duodenal Ulcer; Duodenitis; Helicobacter pylori; Humans; | 1993 |